https://stock.noler.com/us/stock/immune-design-corp https://stock.noler.com/us/stock/immune-design-corp/accounts-payable https://stock.noler.com/us/stock/immune-design-corp/accounts-receivable https://stock.noler.com/us/stock/immune-design-corp/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/immune-design-corp/accrued-liabilities-current https://stock.noler.com/us/stock/immune-design-corp/accrued-professional-fees-current https://stock.noler.com/us/stock/immune-design-corp/accrued-professional-fees-current-and-noncurrent https://stock.noler.com/us/stock/immune-design-corp/accrued-salaries-current https://stock.noler.com/us/stock/immune-design-corp/accumulated-depreciation https://stock.noler.com/us/stock/immune-design-corp/accumulated-oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/immune-design-corp/additional-paid-in-capital https://stock.noler.com/us/stock/immune-design-corp/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/immune-design-corp/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/immune-design-corp/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/immune-design-corp/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/immune-design-corp/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/immune-design-corp/available-for-sale-amortized-cost https://stock.noler.com/us/stock/immune-design-corp/available-for-sale-current https://stock.noler.com/us/stock/immune-design-corp/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/immune-design-corp/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/immune-design-corp/available-for-sale-debt-current https://stock.noler.com/us/stock/immune-design-corp/available-for-sale-debt-securities https://stock.noler.com/us/stock/immune-design-corp/available-for-sale-gross-unrealized-gains https://stock.noler.com/us/stock/immune-design-corp/available-for-sale-gross-unrealized-loss https://stock.noler.com/us/stock/immune-design-corp/available-for-sale-securities https://stock.noler.com/us/stock/immune-design-corp/capital-expenditures https://stock.noler.com/us/stock/immune-design-corp/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/immune-design-corp/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/immune-design-corp/cash-and-equivalents https://stock.noler.com/us/stock/immune-design-corp/cash-and-restricted-cash https://stock.noler.com/us/stock/immune-design-corp/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/immune-design-corp/cash-flow-breakdown https://stock.noler.com/us/stock/immune-design-corp/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/immune-design-corp/commitments-and-contingencies https://stock.noler.com/us/stock/immune-design-corp/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/immune-design-corp/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/immune-design-corp/common-stock-value-outstanding https://stock.noler.com/us/stock/immune-design-corp/comprehensive-income https://stock.noler.com/us/stock/immune-design-corp/contracts-revenue https://stock.noler.com/us/stock/immune-design-corp/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/immune-design-corp/cost-of-goods-sold https://stock.noler.com/us/stock/immune-design-corp/cost-of-revenue https://stock.noler.com/us/stock/immune-design-corp/cost-of-revenue-2 https://stock.noler.com/us/stock/immune-design-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/immune-design-corp/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/immune-design-corp/current-assets https://stock.noler.com/us/stock/immune-design-corp/current-liabilities https://stock.noler.com/us/stock/immune-design-corp/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/immune-design-corp/deferred-offering-costs https://stock.noler.com/us/stock/immune-design-corp/deferred-rent-credit-current https://stock.noler.com/us/stock/immune-design-corp/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/immune-design-corp/deferred-revenue https://stock.noler.com/us/stock/immune-design-corp/deferred-tax-assets-gross https://stock.noler.com/us/stock/immune-design-corp/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/immune-design-corp/deferred-tax-assets-net https://stock.noler.com/us/stock/immune-design-corp/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/immune-design-corp/deferred-tax-assets-other https://stock.noler.com/us/stock/immune-design-corp/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/immune-design-corp/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/immune-design-corp/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/immune-design-corp/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/immune-design-corp/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/immune-design-corp/deposits-assets-noncurrent https://stock.noler.com/us/stock/immune-design-corp/depreciation-and-amortization https://stock.noler.com/us/stock/immune-design-corp/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/immune-design-corp/effective-tax-rate https://stock.noler.com/us/stock/immune-design-corp/employee-related-liabilities-current https://stock.noler.com/us/stock/immune-design-corp/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/immune-design-corp/financing-cash-flow https://stock.noler.com/us/stock/immune-design-corp/form-d-other https://stock.noler.com/us/stock/immune-design-corp/form-d-stocks https://stock.noler.com/us/stock/immune-design-corp/general-and-administrative-expense https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-deposit-other-assets https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-inventories https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-other-deferred-liability https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-restricted-cash-for-operating-activities https://stock.noler.com/us/stock/immune-design-corp/increase-decrease-in-security-deposits https://stock.noler.com/us/stock/immune-design-corp/insider-transactions-preferred https://stock.noler.com/us/stock/immune-design-corp/insider-transactions-stock-options https://stock.noler.com/us/stock/immune-design-corp/insider-transactions-stock-units https://stock.noler.com/us/stock/immune-design-corp/inventory https://stock.noler.com/us/stock/immune-design-corp/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/immune-design-corp/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/immune-design-corp/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/immune-design-corp/inventory-write-down https://stock.noler.com/us/stock/immune-design-corp/investing-cash-flow https://stock.noler.com/us/stock/immune-design-corp/lease-and-rental-expense https://stock.noler.com/us/stock/immune-design-corp/leasehold-improvements-gross https://stock.noler.com/us/stock/immune-design-corp/legal-settlement-proceeds https://stock.noler.com/us/stock/immune-design-corp/letters-of-credit-outstanding-amount https://stock.noler.com/us/stock/immune-design-corp/licenses-revenue https://stock.noler.com/us/stock/immune-design-corp/litigation-reserve-current https://stock.noler.com/us/stock/immune-design-corp/litigation-reserve-noncurrent https://stock.noler.com/us/stock/immune-design-corp/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/immune-design-corp/net-cash-from-financing-activities https://stock.noler.com/us/stock/immune-design-corp/net-cash-from-investing-activities https://stock.noler.com/us/stock/immune-design-corp/net-cash-from-operating-activities https://stock.noler.com/us/stock/immune-design-corp/net-change-in-cash https://stock.noler.com/us/stock/immune-design-corp/net-income https://stock.noler.com/us/stock/immune-design-corp/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/immune-design-corp/number-of-operating-segments https://stock.noler.com/us/stock/immune-design-corp/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/immune-design-corp/operating-cash-flow https://stock.noler.com/us/stock/immune-design-corp/operating-expenses https://stock.noler.com/us/stock/immune-design-corp/operating-income https://stock.noler.com/us/stock/immune-design-corp/operating-lease-payments-due https://stock.noler.com/us/stock/immune-design-corp/operating-lease-payments-due-current https://stock.noler.com/us/stock/immune-design-corp/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/immune-design-corp/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/immune-design-corp/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/immune-design-corp/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/immune-design-corp/operating-leases-rent-expense-minimum-rentals https://stock.noler.com/us/stock/immune-design-corp/operating-loss-carryforwards https://stock.noler.com/us/stock/immune-design-corp/other-accrued-liabilities-current https://stock.noler.com/us/stock/immune-design-corp/other-current-assets https://stock.noler.com/us/stock/immune-design-corp/other-noncash-income-expense https://stock.noler.com/us/stock/immune-design-corp/other-noncurrent-assets https://stock.noler.com/us/stock/immune-design-corp/other-noncurrent-liabilities https://stock.noler.com/us/stock/immune-design-corp/other-nonoperating-income-expense https://stock.noler.com/us/stock/immune-design-corp/other-receivables-net-current https://stock.noler.com/us/stock/immune-design-corp/other-sales-revenue-net https://stock.noler.com/us/stock/immune-design-corp/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/immune-design-corp/payments-for-deposits https://stock.noler.com/us/stock/immune-design-corp/payments-for-restructuring https://stock.noler.com/us/stock/immune-design-corp/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/immune-design-corp/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/immune-design-corp/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/immune-design-corp/preferred-shares-facts https://stock.noler.com/us/stock/immune-design-corp/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/immune-design-corp/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/immune-design-corp/preferred-stock-shares-authorized https://stock.noler.com/us/stock/immune-design-corp/preferred-stock-shares-issued https://stock.noler.com/us/stock/immune-design-corp/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/immune-design-corp/preferred-stock-value-outstanding https://stock.noler.com/us/stock/immune-design-corp/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/immune-design-corp/prepaid-expense-current https://stock.noler.com/us/stock/immune-design-corp/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/immune-design-corp/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/immune-design-corp/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/immune-design-corp/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/immune-design-corp/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/immune-design-corp/proceeds-from-stock-issued https://stock.noler.com/us/stock/immune-design-corp/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/immune-design-corp/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/immune-design-corp/property-plant-and-equipment-gross https://stock.noler.com/us/stock/immune-design-corp/property-plant-equipment https://stock.noler.com/us/stock/immune-design-corp/public-float https://stock.noler.com/us/stock/immune-design-corp/research-and-development https://stock.noler.com/us/stock/immune-design-corp/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/immune-design-corp/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/immune-design-corp/restricted-cash-current https://stock.noler.com/us/stock/immune-design-corp/restructuring-and-related-cost-expected-cost-remaining https://stock.noler.com/us/stock/immune-design-corp/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/immune-design-corp/retained-earnings https://stock.noler.com/us/stock/immune-design-corp/revenue https://stock.noler.com/us/stock/immune-design-corp/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/immune-design-corp/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/immune-design-corp/sales-revenue-goods-net https://stock.noler.com/us/stock/immune-design-corp/security-deposit https://stock.noler.com/us/stock/immune-design-corp/severance-costs https://stock.noler.com/us/stock/immune-design-corp/shareholders-equity https://stock.noler.com/us/stock/immune-design-corp/shares-authorized https://stock.noler.com/us/stock/immune-design-corp/shares-issued https://stock.noler.com/us/stock/immune-design-corp/short-term-investments https://stock.noler.com/us/stock/immune-design-corp/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/immune-design-corp/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/immune-design-corp/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/immune-design-corp/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/immune-design-corp/stock-based-compensation https://stock.noler.com/us/stock/immune-design-corp/stock-issued-new-shares-sold https://stock.noler.com/us/stock/immune-design-corp/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/immune-design-corp/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/immune-design-corp/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/immune-design-corp/stock-issued-shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/immune-design-corp/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/immune-design-corp/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/immune-design-corp/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/immune-design-corp/stock-options-exercisable-number https://stock.noler.com/us/stock/immune-design-corp/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/immune-design-corp/stock-options-expirations-in-period https://stock.noler.com/us/stock/immune-design-corp/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/immune-design-corp/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/immune-design-corp/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/immune-design-corp/stock-options-nonvested-options-forfeited-number-of-shares https://stock.noler.com/us/stock/immune-design-corp/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/immune-design-corp/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/immune-design-corp/stock-options-outstanding-number https://stock.noler.com/us/stock/immune-design-corp/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/immune-design-corp/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/immune-design-corp/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/immune-design-corp/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/immune-design-corp/stock-split-ratio https://stock.noler.com/us/stock/immune-design-corp/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/immune-design-corp/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/immune-design-corp/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/immune-design-corp/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/immune-design-corp/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-amount https://stock.noler.com/us/stock/immune-design-corp/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/immune-design-corp/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/immune-design-corp/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/immune-design-corp/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/immune-design-corp/temporary-equity-shares-authorized https://stock.noler.com/us/stock/immune-design-corp/temporary-equity-shares-issued https://stock.noler.com/us/stock/immune-design-corp/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/immune-design-corp/total-assets https://stock.noler.com/us/stock/immune-design-corp/total-liabilities-and-equity https://stock.noler.com/us/stock/immune-design-corp/unrecognized-tax-benefits https://stock.noler.com/us/stock/immune-design-corp/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/immune-design-corp/warrants-and-rights-outstanding https://stock.noler.com/us/stock/immune-design-corp/weighted-average-number-of-share-outstanding-basic-and-diluted